Drug Shortage Report for MYLAN-VERAPAMIL SR
| Report ID | 200642 |
| Drug Identification Number | 02210347 |
| Brand name | MYLAN-VERAPAMIL SR |
| Common or Proper name | VERAPAMIL SR |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE |
| Strength(s) | 120MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100BT |
| ATC code | C08DA |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-10-03 |
| Actual start date | 2023-10-05 |
| Estimated end date | 2024-02-13 |
| Actual end date | 2024-02-09 |
| Shortage status | Resolved |
| Updated date | 2024-02-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2024-02-21 | French | Compare |
| v20 | 2024-02-21 | English | Compare |
| v19 | 2024-01-10 | French | Compare |
| v18 | 2024-01-10 | English | Compare |
| v17 | 2023-12-19 | French | Compare |
| v16 | 2023-12-19 | English | Compare |
| v15 | 2023-11-14 | French | Compare |
| v14 | 2023-11-14 | English | Compare |
| v13 | 2023-10-30 | French | Compare |
| v12 | 2023-10-30 | English | Compare |
| v11 | 2023-10-11 | French | Compare |
| v10 | 2023-10-11 | English | Compare |
| v9 | 2023-10-04 | English | Compare |
| v8 | 2023-10-03 | French | Compare |
| v7 | 2023-10-03 | English | Compare |
| v6 | 2023-09-28 | English | Compare |
| v5 | 2023-09-20 | French | Compare |
| v4 | 2023-09-20 | English | Compare |
| v3 | 2023-09-05 | English | Compare |
| v2 | 2023-08-01 | French | Compare |